BUSINESS● ELEVATED11h ago · Oct 13, 2026, 1:32 PM
Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
CNBC · north america
Shkreli was banned from the pharmaceutical industry after a trial found that he organized an illegal scheme to perpetuate a monopoly for the drug Daraprim.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoWhy did Hong Kong’s 11 Skies fail and can the megaproject be rescued?South China Morning PostBUSINESS22m agoSingapore third-quarter GDP growth softens from four-year high but beats estimatesCNBC